ACE Report Cover
TKA: Postoperative opiate use lowered by intraoperative periarticular LIA
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
ARTHROPLASTY
TKA: Postoperative opiate use lowered by intraoperative periarticular LIA .
Verified
This report has been verified by one or more authors of the original publication.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2015;3(6):3 Acta Orthop. 2014 Dec;85(6):614-9.

60 patients undergoing primary total knee arthroplasty were randomized to receive either a periarticular local infiltration analgesia (LIA) with levobupivacaine, ketorolac, and adrenaline versus a placebo injection of saline. Oxycodone consumption, pain, and range of motion were measured over 48 hours postoperatively, and functional outcomes were evaluated 1 year following surgery. The results of this study suggest that LIA reduced cumulative oxycodone consumption over the first 24 postoperative hours, with effect mainly occurring within the first 6 hours after surgery. Knee range of motion was also greater at 6 hours in those who received LIA, though no significant differences were detected at 24 and 48h. Functional outcomes were similar between groups at 1 year.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Not Reported
Conflitti:
None disclosed

Rischio di pregiudizio

9/10

Criteri di segnalazione

19/20

Indice di fragilità

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

4/4

Randomization

3/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

Multimodal pain management in total knee arthroplasty aims to reduce opiate use and its inherent side effects. The role of local infiltration analgesia (LIA) in multimodal regimens has yet to be fully characterized within the knee arthroplasty arena. This study aimed to assess the effect of a single, intraoperative periarticular infiltration levobupivacaine, ketorolac, and adrenaline on postoperative pain and opioid consumption following TKA.

Qual era la domanda di ricerca principale?

Does a single, intraoperative periarticular infiltration of levobupivacaine, ketorolac, and adrenaline have a significant impact on oxycodone consumption following total knee arthroplasty?

Caratteristiche dello studio +
Population:
60 patients (between 18 and 75 year old) undergoing standard primary total knee arthroplasty due to osteoarthritis. Exclusion criteria included rheumatoid arthritis, Patients with rheumatoid arthritis, >15 varus or valgus deformity, BMI >35 or previous high tibial osteotomy/osteosynthesis All cases were performed under spinal anaesthesia. All patients were begun on patient-controlled analgesia (oxycodone) postoperatively (2mg; 8min lockout).
Intervention:
LIA group: Patients received intraoperative administration of periarticular local infiltration analgesia using a 100mL solution of 150 mg levobupivacaine, 30 mg ketorolac and 0.5 mg adrenaline (n=27, 26 completed follow up; 12M/15F) (Mean age: 65 +/- 4.9)
Comparison:
Placebo group: Patients received intraoperative administration of 100mL of isotonic saline periarticularly (n=29, 25 completed follow up; 15M/14F) (Mean age: 64 +/- 6.7)
Outcomes:
The primary outcome was oxycodone consumption over 48 hours postoperatively. Secondary outcomes include functional outcome through the Total Knee Function Questionnaire (TKFQ), Oxford Knee Score (OKS), High-Activity Arthroplasty Score (HAAS). The 15D quality-of-life instrument was used for prospective outcome analysis.
Methods:
RCT; Double blind; Placebo-controlled; Single-centre.
Time:
Oxycodone consumption was measured after 48 hours postoperatively. Total Knee Function Questionnaire (TKFQ), Oxford Knee Score (OKS), High-Activity Arthroplasty Score (HAAS) were measured 1 year following the study. Follow up with a physiotherapist occurred 3 months postoperatively and the 15D instrument was used preoperatively, at 3 months, and at 1 year following surgery.
Quali erano i risultati importanti?
  • Cumulative oxycodone consumption for the first 24 hours after surgery was significantly lower in the LIA group than in the placebo group; oxycodone consumption in the LIA group was 17mg lower than the placebo group after 6h (p<0.001), 20mg lower after 12h (p<0.001), and 28mg lower after 24h (p=0.03).
  • Time interval-based oxycodone consumption was significantly lower in the LIA group compared to the placebo group from 0-6h (p<0.001), though differences were not statistically significant for 6-12h (p=0.09), 12-24h (p=0.1), or 24-48h (p=0.04) time intervals.
  • Median VAS scores of <3 were considered an adequate level of pain management. This was achieved in both groups 48 hours potsoperatively. Groups did not demonstrate statistically significant differences at any time point (all p>0.05).
  • Mean range of motion (ROM) at 6 hours was significant greater in the LIA group compared to the placebo group (26deg difference; p<0.001). Groups did not significantly differ in knee ROM at 24h (p=0.08) or 48h (p=0.6).
  • Functional outcomes between groups at 1 year follow up were not significantly different between groups, as measured by HAAS, OKS and 15D quality-of-life instrument.
Che cosa devo ricordare di più?

In total knee arthroplasty, total consumption of oxycodone over the first 24 hours postoperatively was significant lowered by the use of a single intraoperative infiltration containing levobupivacaine, ketorolac, and adrenaline when compared to those who received placebo. LIA effect was predominantly seen within the first 6 hours after surgery. LIA patients also improved early knee range of motion, although there was no functional difference between groups at 1 year postoperatively.

Come influenzerà l'assistenza ai miei pazienti?

The combined use of levobupivacaine, ketorolac, and adrenaline in a single, intraoperative paeriarticular infiltration in total knee arthroplasty appears to be beneficial in terms of lowering the use of patient-controlled opioids in the early postoperative period. The study suggests that local infiltration analgesia may be used as an adjunct to oral medical in patients undergoing total knee arthroplasty, though effects appear to be limited to analgesic outcomes immediately postoperatively. Future research should consider the possible impact of LIA in a multimodal regimen on rehabilitation progression and time to discharge.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Close Dialog
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. TKA: Postoperative opiate use lowered by intraoperative periarticular LIA. OE Journal. 2015;3(6):3. Available from: https://myorthoevidence.com/AceReport/Show/tka-postoperative-opiate-use-lowered-by-intraoperative-periarticular-lia

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report